{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T19:11:07Z","timestamp":1761419467320},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>An increased incidence of narcolepsy type 1 (NT1) was observed in Scandinavia following the 2009\u20132010 influenza Pandemrix vaccination. The association between NT1 and <jats:italic>HLA-DQB1*06:02:01<\/jats:italic> supported the view of the vaccine as an etiological agent. A\/H1N1 hemagglutinin (HA) is the main antigenic determinant of the host neutralization antibody response. Using two different immunoassays, the Luciferase Immunoprecipitation System (LIPS) and Radiobinding Assay (RBA), we investigated HA antibody levels and affinity in an exploratory and in a confirmatory cohort of Swedish NT1 patients and healthy controls vaccinated with Pandemrix. HA antibodies were increased in NT1 patients compared to controls in the exploratory (LIPS p\u2009=\u20090.0295, RBA p\u2009=\u20090.0369) but not in the confirmatory cohort (LIPS p\u2009=\u20090.55, RBA p\u2009=\u20090.625). HA antibody affinity, assessed by competition with Pandemrix vaccine, was comparable between patients and controls (LIPS: 48 vs. 39\u00a0ng\/ml, p\u2009=\u20090.81; RBA: 472 vs. 491\u00a0ng\/ml, p\u2009=\u20090.65). The LIPS assay also detected higher HA antibody titres as associated with <jats:italic>HLA-DQB1*06:02:01<\/jats:italic> (p\u2009=\u20090.02). Our study shows that following Pandemrix vaccination, HA antibodies levels and affinity were comparable NT1 patients and controls and suggests that HA antibodies are unlikely to play a role in NT1 pathogenesis.<\/jats:p>","DOI":"10.1038\/s41598-021-83543-z","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T09:14:59Z","timestamp":1613812499000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A\/H1N1 hemagglutinin antibodies show comparable affinity in vaccine-related Narcolepsy type 1 and control and are unlikely to contribute to pathogenesis"],"prefix":"10.1038","volume":"11","author":[{"given":"Alexander","family":"Lind","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Marzinotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Brigatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Ramelius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Piemonti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vito","family":"Lampasona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,18]]},"reference":[{"key":"83543_CR1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/joim.12150","volume":"275","author":"I Persson","year":"2014","unstructured":"Persson, I. et al. Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: A population- and registry-based cohort study with over 2 years of follow-up. J. Intern. Med. 275, 172\u2013190 (2014).","journal-title":"J. Intern. Med."},{"key":"83543_CR2","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1212\/WNL.0b013e31828ab26f","volume":"80","author":"A Szakacs","year":"2013","unstructured":"Szakacs, A., Darin, N. & Hallbook, T. Increased childhood incidence of narcolepsy in western Sweden after H1N1 influenza vaccination. Neurology 80, 1315\u20131321 (2013).","journal-title":"Neurology"},{"key":"83543_CR3","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.sleep.2013.03.020","volume":"14","author":"MS Heier","year":"2013","unstructured":"Heier, M. S. et al. Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Sleep Med. 14, 867\u2013871 (2013).","journal-title":"Sleep Med."},{"key":"83543_CR4","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.vaccine.2017.02.053","volume":"35","author":"L Trogstad","year":"2017","unstructured":"Trogstad, L. et al. Narcolepsy and hypersomnia in Norwegian children and young adults following the influenza A(H1N1) 2009 pandemic. Vaccine 35, 1879\u20131885 (2017).","journal-title":"Vaccine"},{"key":"83543_CR5","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1002\/pds.4788","volume":"28","author":"F Granath","year":"2019","unstructured":"Granath, F., Gedeborg, R., Smedje, H. & Feltelius, N. Change in risk for narcolepsy over time and impact of definition of onset date following vaccination with AS03 adjuvanted pandemic A\/H1N1 influenza vaccine (Pandemrix) during the 2009 H1N1 influenza pandemic. Pharmacoepidemiol. Drug Saf. 28, 1045\u20131053 (2019).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"83543_CR6","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/joim.12391","volume":"278","author":"N Feltelius","year":"2015","unstructured":"Feltelius, N. et al. A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009\u20132010 Pandemrix vaccination programme in Sweden. J. Intern. Med. 278, 335\u2013353 (2015).","journal-title":"J. Intern. Med."},{"key":"83543_CR7","doi-asserted-by":"publisher","first-page":"e33723","DOI":"10.1371\/journal.pone.0033723","volume":"7","author":"M Partinen","year":"2012","unstructured":"Partinen, M. et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 Pandemic vaccination campaign in Finland. PLoS ONE 7, e33723 (2012).","journal-title":"PLoS ONE"},{"key":"83543_CR8","doi-asserted-by":"publisher","first-page":"e33536","DOI":"10.1371\/journal.pone.0033536","volume":"7","author":"H Nohynek","year":"2012","unstructured":"Nohynek, H. et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS ONE 7, e33536 (2012).","journal-title":"PLoS ONE"},{"key":"83543_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.smrv.2017.06.006","volume":"38","author":"TO Sarkanen","year":"2018","unstructured":"Sarkanen, T. O., Alakuijala, A. P. E., Dauvilliers, Y. A. & Partinen, M. M. Incidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis. Sleep Med. Rev. 38, 177\u2013186 (2018).","journal-title":"Sleep Med. Rev."},{"key":"83543_CR10","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/ana.22587","volume":"70","author":"F Han","year":"2011","unstructured":"Han, F. et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann. Neurol. 70, 410\u2013417 (2011).","journal-title":"Ann. Neurol."},{"key":"83543_CR11","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/ana.23799","volume":"73","author":"F Han","year":"2013","unstructured":"Han, F., Lin, L., Li, J., Dong, X. S. & Mignot, E. Decreased incidence of childhood narcolepsy 2 years after the 2009 H1N1 winter flu pandemic. Ann. Neurol. 73, 560\u2013560 (2013).","journal-title":"Ann. Neurol."},{"key":"83543_CR12","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.sleep.2018.10.036","volume":"66","author":"W-T Huang","year":"2020","unstructured":"Huang, W.-T. et al. Narcolepsy and 2009 H1N1 pandemic vaccination in Taiwan. Sleep Med. 66, 276\u2013281 (2020).","journal-title":"Sleep Med."},{"key":"83543_CR13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.sleep.2013.12.012","volume":"15","author":"H Wu","year":"2014","unstructured":"Wu, H. et al. Symptoms and occurrences of narcolepsy: a retrospective study of 162 patients during a 10-year period in Eastern China. Sleep Med. 15, 607\u2013613 (2014).","journal-title":"Sleep Med."},{"key":"83543_CR14","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","volume":"27","author":"TC Thannickal","year":"2000","unstructured":"Thannickal, T. C. et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27, 469\u2013474 (2000).","journal-title":"Neuron"},{"key":"83543_CR15","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1056\/NEJMra1500587","volume":"373","author":"TE Scammell","year":"2015","unstructured":"Scammell, T. E. Narcolepsy. N. Engl. J. Med. 373, 2654\u20132662 (2015).","journal-title":"N. Engl. J. Med."},{"key":"83543_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2016.100","volume":"3","author":"BR Kornum","year":"2017","unstructured":"Kornum, B. R. et al. Narcolepsy. Nat. Rev. Dis. Primers 3, 1\u201319 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"83543_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5665\/sleep.3300","volume":"37","author":"M Tafti","year":"2014","unstructured":"Tafti, M. et al. DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. Sleep 37, 19\u201325 (2014).","journal-title":"Sleep"},{"key":"83543_CR18","doi-asserted-by":"publisher","first-page":"e0222882","DOI":"10.1371\/journal.pone.0222882","volume":"14","author":"A Lind","year":"2019","unstructured":"Lind, A. et al. HLA high-resolution typing by next-generation sequencing in Pandemrix-induced narcolepsy. PLoS ONE 14, e0222882 (2019).","journal-title":"PLoS ONE"},{"key":"83543_CR19","doi-asserted-by":"publisher","first-page":"e68402","DOI":"10.1371\/journal.pone.0068402","volume":"8","author":"K Mel\u00e9n","year":"2013","unstructured":"Mel\u00e9n, K. et al. No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after pandemrix vaccination campaign in Finland. PLoS ONE 8, e68402 (2013).","journal-title":"PLoS ONE"},{"key":"83543_CR20","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1089\/vim.2017.0066","volume":"30","author":"A Lind","year":"2017","unstructured":"Lind, A. et al. Antibody affinity against 2009 A\/H1N1 influenza and pandemrix vaccine nucleoproteins differs between childhood narcolepsy patients and controls. Viral Immunol. 30, 590\u2013600 (2017).","journal-title":"Viral Immunol."},{"key":"83543_CR21","doi-asserted-by":"publisher","first-page":"e114361","DOI":"10.1371\/journal.pone.0114361","volume":"9","author":"O Vaarala","year":"2014","unstructured":"Vaarala, O. et al. Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: Implications for pandemrix-associated narcolepsy risk. PLoS ONE 9, e114361 (2014).","journal-title":"PLoS ONE"},{"key":"83543_CR22","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1126\/scitranslmed.aab2354","volume":"7","author":"SS Ahmed","year":"2015","unstructured":"Ahmed, S. S. et al. Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. Sci. Transl. Med. 7, 294 (2015).","journal-title":"Sci. Transl. Med."},{"key":"83543_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/sleep\/zsw070","volume":"40","author":"M Ramberger","year":"2017","unstructured":"Ramberger, M. et al. CD4+ T-cell reactivity to orexin\/hypocretin in patients with narcolepsy type 1. Sleep 40, 2 (2017).","journal-title":"Sleep"},{"key":"83543_CR24","doi-asserted-by":"publisher","first-page":"E12323","DOI":"10.1073\/pnas.1818150116","volume":"115","author":"G Luo","year":"2018","unstructured":"Luo, G. et al. Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy. Proc. Natl. Acad. Sci. U.S.A. 115, E12323\u2013E12332 (2018).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"83543_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41586-018-0540-1","volume":"562","author":"D Latorre","year":"2018","unstructured":"Latorre, D. et al. T cells in patients with narcolepsy target self-antigens of hypocretin neurons. Nature 562, 63\u201368 (2018).","journal-title":"Nature"},{"key":"83543_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jneuroim.2017.05.001","volume":"309","author":"BR Kornum","year":"2017","unstructured":"Kornum, B. R. et al. Absence of autoreactive CD4+ T-cells targeting HLA-DQA1*01:02\/DQB1*06:02 restricted hypocretin\/orexin epitopes in narcolepsy type 1 when detected by EliSpot. J. Neuroimmunol. 309, 7\u201311 (2017).","journal-title":"J. Neuroimmunol."},{"key":"83543_CR27","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.1038\/s41467-019-13234-x","volume":"10","author":"W Jiang","year":"2019","unstructured":"Jiang, W. et al. In vivo clonal expansion and phenotypes of hypocretin-specific CD4 + T cells in narcolepsy patients and controls. Nat. Commun. 10, 5247 (2019).","journal-title":"Nat. Commun."},{"key":"83543_CR28","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1002\/acn3.50908","volume":"6","author":"AC Cogswell","year":"2019","unstructured":"Cogswell, A. C. et al. Children with Narcolepsy type 1 have increased T-cell responses to orexins. Ann. Clin. Transl. Neurol. 6, 2566\u20132572 (2019).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"83543_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jneuroim.2019.04.009","volume":"332","author":"MS Schinkelshoek","year":"2019","unstructured":"Schinkelshoek, M. S. et al. H1N1 hemagglutinin-specific HLA-DQ6-restricted CD4+ T cells can be readily detected in narcolepsy type 1 patients and healthy controls. J. Neuroimmunol. 332, 167\u2013175 (2019).","journal-title":"J. Neuroimmunol."},{"key":"83543_CR30","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.clim.2007.08.005","volume":"125","author":"E Liu","year":"2007","unstructured":"Liu, E. & Eisenbarth, G. S. Accepting clocks that tell time poorly: Fluid-phase versus standard ELISA autoantibody assays. Clin. Immunol. 125, 120\u2013126 (2007).","journal-title":"Clin. Immunol."},{"issue":"Suppl 2","key":"83543_CR31","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.2337\/diabetes.54.suppl_2.S52","volume":"54","author":"C Pihoker","year":"2005","unstructured":"Pihoker, C., Gilliam, L. K., Hampe, C. S. & Lernmark, A. Autoantibodies in diabetes. Diabetes 54(Suppl 2), S52-61 (2005).","journal-title":"Diabetes"},{"key":"83543_CR32","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/0140-6736(92)91829-W","volume":"339","author":"O Winqvist","year":"1992","unstructured":"Winqvist, O., Karlsson, F. A. & K\u00e4mpe, O. 21-hydroxylase, a major autoantigen in idiopathic Addison\u2019s disease. Lancet 339, 1559\u20131562 (1992).","journal-title":"Lancet"},{"key":"83543_CR33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jaut.2014.01.031","volume":"50","author":"A Lind","year":"2014","unstructured":"Lind, A. et al. A\/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009\u20132010. J. Autoimmun. 50, 99\u2013106 (2014).","journal-title":"J. Autoimmun."},{"key":"83543_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/gene.2017.1","volume":"18","author":"IL Bomfim","year":"2017","unstructured":"Bomfim, I. L. et al. The immunogenetics of narcolepsy associated with A(H1N1)pdm09 vaccination (Pandemrix) supports a potent gene\u2013environment interaction. Genes Immun. 18, 75\u201381 (2017).","journal-title":"Genes Immun."},{"key":"83543_CR35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1126\/scitranslmed.3009995","volume":"6","author":"AK De la Herr\u00e1n-Arita","year":"2014","unstructured":"De la Herr\u00e1n-Arita, A. K. et al. Retraction of the research article: \u2018CD4+ T cell autoimmunity to hypocretin\/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy\u2019. Sci. Transl. Med. 6, 247 (2014).","journal-title":"Sci. Transl. Med."},{"key":"83543_CR36","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.1172\/JCI142804","volume":"130","author":"M Secchi","year":"2020","unstructured":"Secchi, M. et al. COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain. J. Clin. Investig. 130, 6366\u20136378 (2020).","journal-title":"J. Clin. Investig."},{"key":"83543_CR37","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/08916934.2019.1643843","volume":"52","author":"M Wallenius","year":"2019","unstructured":"Wallenius, M. et al. Autoantibodies in Pandemrix\u00ae-induced narcolepsy: Nine candidate autoantigens fail the conformational autoantibody test. Autoimmunity 52, 185\u2013191 (2019).","journal-title":"Autoimmunity"},{"key":"83543_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1073\/pnas.1308701110","volume":"111","author":"Y Lu","year":"2014","unstructured":"Lu, Y., Welsh, J. P. & Swartz, J. R. Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines. Proc. Natl. Acad. Sci. U.S.A. 111, 125\u2013130 (2014).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"83543_CR39","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jim.2006.06.003","volume":"314","author":"AJK Williams","year":"2006","unstructured":"Williams, A. J. K., Norcross, A. J., Chandler, K. A. & Bingley, P. J. Non-specific binding to protein A Sepharose and protein G Sepharose in insulin autoantibody assays may be reduced by pre-treatment with glycine or ethanolamine. J. Immunol. Methods 314, 170\u2013173 (2006).","journal-title":"J. Immunol. Methods"},{"key":"83543_CR40","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/BF00408469","volume":"37","author":"CE Grubin","year":"1994","unstructured":"Grubin, C. E. et al. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37, 344\u2013350 (1994).","journal-title":"Diabetologia"},{"key":"83543_CR41","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. (R Foundation for Statistical Computing, 2020)."},{"key":"83543_CR42","doi-asserted-by":"publisher","first-page":"e0146021","DOI":"10.1371\/journal.pone.0146021","volume":"10","author":"C Ritz","year":"2015","unstructured":"Ritz, C., Baty, F., Streibig, J. C. & Gerhard, D. Dose-response analysis using R. PLoS ONE 10, e0146021 (2015).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83543-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83543-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83543-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T03:45:51Z","timestamp":1670039151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83543-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,18]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["83543"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-83543-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,18]]},"assertion":[{"value":"27 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4063"}}